HOLON, Israel, January 30, 2017 /PRNewswire/ --
Compugen Ltd. (NASDAQ: CGEN), a leading
predictive drug discovery company, today announced that the Company
will host a conference call on Wednesday,
February 15, 2017 at 10:00 AM
EST to review fourth quarter and yearend 2016 results.
Compugen participants on the conference call will include
Martin Gerstel, Chairman; Dr.
Anat Cohen-Dayag, President and CEO;
and Ari Krashin, CFO. The quarterly
and yearend results will be released on the Company's website
(http://www.cgen.com) prior to the call.
To access the conference call, please dial 1-888-668-9141 from
the US, or +972-3-9180609 internationally. The call will also be
available via live webcast through Compugen's website, located at
the following link.
A replay of the conference call will be available approximately
two hours after the completion of the live conference call. To
access the replay, please dial 1-888-326-9310 from the US or
+972-3-9255904 internationally. The replay will be available
through February 18, 2017.
About Compugen
Compugen is a leading therapeutic discovery company utilizing
its broadly applicable predictive discovery infrastructure to
identify novel drug targets and develop first-in-class biologics.
The primary focus of the Company's current pipeline is on immune
checkpoint target candidates discovered by the Company, potentially
providing the basis for a next wave of therapeutics for cancer
immunotherapy. Compugen's business model is based on selectively
entering into collaborations for its novel target candidates and
drug product candidates at various stages of research and
development under revenue-sharing agreements. The Company is
headquartered in Israel, with
R&D facilities in Israel and
South San Francisco. At the US facilities, monoclonal antibody
therapeutic candidates are discovered and developed against the
Company's novel target candidates. For additional information,
please visit Compugen's corporate website at
http://www.cgen.com.
Company contact:
Susanna Chau
Director, Investor Relations and Corporate Communications
Compugen
Email: susannac@cgen.com
Tel: +1-(650)-263-7001
SOURCE Compugen Ltd.